MINNEAPOLIS, July 17 /PRNewswire-FirstCall/ -- Uroplasty, Inc. announced today that it will release financial results for the first quarter of fiscal 2009 ended June 30, 2008, at the close of the market on Thursday, July 31, 2008. The Company will host a conference call to discuss these results on Thursday, July 31, 2008 at 3:30 p.m. Central, 4:30 p.m. Eastern. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 866-249-5225 (domestic) or 303-262-2131 (international). An audio replay will be available for thirty days following the call at 800-405-2236 (domestic) or 303-590-3000 (international), with the passcode 11117192#.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC(R) system, which we believe is the only FDA-approved minimally invasive nerve stimulation device designed for office-based treatment of symptoms often associated with overactive bladder. We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.
CONTACT: David Kaysen, President and CEO or Medi Jiwani, Vice President,
CFO, and Treasurer, both of Uroplasty, Inc., +1-952-426-6140; or investors,
Dahlia Bailey, +1-415-896-6820, or media, Chris Gale, +1-646-201-5445, both
of EVC Group, for Uroplasty, Inc.
Web site: http://www.uroplasty.com/
